Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.58 -0.05 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $18.00 | |||
| Open | $4.59 | 52 Week Low | $6.91 | |||
| Day High | $4.60 | P/E | N/A | |||
| Day Low | $4.49 | EPS | $-0.67 | |||
| Volume | 726,287 | |||||
